IL-17+-producing T cells were elevated in the active rather than in inactive areas of MS lesions, and significantly higher densities presented within acute lesions and active borders of chronic active lesions than in normal-appearing white matter (3). This evidence concerns the gene IL17A and myeloid sarcoma.